4.6 Article

Adjuvant chemotherapy for high-grade appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Iterative Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Adenocarcinoma of the Appendix

Felipe Lopez-Ramirez et al.

Summary: This study analyzed the recurrence of mucinous carcinomatosis peritonei (MCP) after the first cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) for appendiceal tumors (AT) and compared the outcomes between patients who underwent iterative CRS/HIPEC and those who did not. The study found that selected low- and high-grade appendiceal cancer patients with MCP recurrence who were able to undergo iterative CRS/HIPEC procedures showed favorable outcomes. However, there was no evidence supporting a survival benefit with iterative CRS/HIPEC in recurrent MCP with signet ring cell morphology.

ANNALS OF SURGICAL ONCOLOGY (2022)

Meeting Abstract Oncology

Correlation of circulating tumor DNA (ctDNA) with clinical outcomes in appendiceal cancers (AC)

Vishesh Kothary et al.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Oncology

Clinical and Radiologic Predictors of a Pathologic Complete Response to Neoadjuvant Chemotherapy (NACT) in Patients Undergoing Cytoreductive Surgery for Colorectal Peritoneal Metastases: Results of a Prospective Multi-center Study

Aditi Bhatt et al.

Summary: The study found that the surgical Peritoneal Cancer Index (sPCI) and radiologic Peritoneal Cancer Index (rPCI) were not accurate predictors of pathologic complete response (pCR) after cytoreductive surgery for colorectal peritoneal metastases. Patients with an sPCI of 3 or lower had an 80% probability of experiencing pCR. The impact of KRAS gene mutations on pCR should be further evaluated.

ANNALS OF SURGICAL ONCOLOGY (2021)

Article Oncology

Surgical and oncological outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a nonacademic center: 25-year experience

Andrei Nikiforchin et al.

Summary: CRS/HIPEC in a non-academic setting is a safe option for treating PSM with favorable surgical and oncological outcomes, despite the presence of major complications and low mortality rates. Incomplete cytoreduction and major complication rates decrease over time, while mortality remains low and constant.

JOURNAL OF SURGICAL ONCOLOGY (2021)

Article Surgery

The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery

Shigeki Kusamura et al.

Summary: This cohort study compared outcomes between PMP patients undergoing CRS with HIPEC and CRS alone, finding HIPEC to be associated with improved overall survival.

JAMA SURGERY (2021)

Article Oncology

Impact of adjuvant chemotherapy on outcomes in appendiceal cancer

Bhaskar C. Kolla et al.

CANCER MEDICINE (2020)

Article Oncology

Patterns of metachronous metastases after curative treatment of colorectal cancer

Yvette R. B. M. van Gestel et al.

CANCER EPIDEMIOLOGY (2014)

Article Oncology

Importance of Histologic Subtype in the Staging of Appendiceal Tumors

Kiran K. Turaga et al.

ANNALS OF SURGICAL ONCOLOGY (2012)

Article Oncology

Neoplasms of the Appendix Current Treatment Guidelines

Suven Shankar et al.

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2012)

Review Medicine, General & Internal

Association Between Time to Initiation of Adjuvant Chemotherapy and Survival in Colorectal Cancer A Systematic Review and Meta-analysis

James J. Biagi et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)

Article Oncology

Pharmacologic rationale for treatments of peritoneal surface malignancy from colorectal cancer

Paul H. Sugarbaker et al.

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2010)